Home > Offer to Sell > Pharmaceuticals and Biochemicals > Antibiotic and antimicrobial agents > Ofloxacin Tablets 100986-85-4

Ofloxacin Tablets 100986-85-4

Inquiry
  Post Date: Nov 05,2024
  Expiry Date: Nov 05,2025
  Detailed Description: Cas No. :100986-85-4 Quantity: 1FCL
Price:1 USD FCL
Payment Method: TT, LC


  CAS Registry Number:

100986-85-4

  Synonyms: ;(+-)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;7H-Pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (+-)-;Floxin;Floxin Otic;Ofloxacin Otic;Ofloxacina;Ofloxacine;Ofloxacino;Ofloxacinum;Oxaldin;OFLX;(-)-Ofloxacin;(S)-(-)-Ofloxacin;(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;(S)-Ofloxacin;Levaquin;Levofloxacino;Levofloxacinum;Ofloxacin S-(-)-form;Levofloxacin;(-)-(S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazin-yl)-7-oxo-7H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid;9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;(3S)-9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid;
  Molecular Formula: C18H20O4N3F
  Molecular Weight: 361.3675
  Molecular Structure: 100986-85-4 ofloxacin
  Safety Description: S22:;
S24/25:;

  Company: Shanghai DND Pharm-Technology Co., Inc.     [ China ]          
  Contact: Arron Yu
  Tel: 021-58783620
  Fax: 021-58783595
  Email: sales@dndpharm.com
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.